Lawsuit alleges intrathecal iodine contrast injection during myelogram caused paraplegia

A lawsuit alleges a Stanford Medicine provider injected Omnipaque 350 (iodine contrast) intrathecally during a routine myelogram, leaving a 75-year-old woman unable to move her legs, with FDA black-box warning against intrathecal use of that concentration.

• The lawsuit names Stanford Medicine, a neurosurgeon, and a radiologic technologist, alleging failure to obtain informed consent and breach of duty.
• The FDA black-box warning for Omnipaque 350 specifically warns against intrathecal administration due to risk of death, seizures, paralysis, or coma.
• The patient, who had a baclofen pump, experienced rapid neurological decline and now requires mobility assistance.

Allegations from a civil lawsuit; medical details and defendant responses are not independently verified from this article.

Automated summary

RadPigeon summaries are original and for information only. They are not clinical advice.